LEADER 05284nam 22006855 450 001 9910298405203321 005 20200702235052.0 010 $a3-319-99286-4 024 7 $a10.1007/978-3-319-99286-0 035 $a(CKB)4100000007108262 035 $a(MiAaPQ)EBC5558164 035 $a(DE-He213)978-3-319-99286-0 035 $a(Au-PeEL)EBL5558164 035 $a(OCoLC)1059418290 035 $a(PPN)231461453 035 $a(EXLCZ)994100000007108262 100 $a20181015d2018 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMolecular & Diagnostic Imaging in Prostate Cancer$b[electronic resource] $eClinical Applications and Treatment Strategies /$fedited by Heide Schatten 205 $a1st ed. 2018. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018. 215 $a1 online resource (xi, 194 pages) $cillustrations 225 1 $aAdvances in Experimental Medicine and Biology,$x0065-2598 ;$v1126 311 $a3-319-99285-6 327 $a1. The role of imaging in clinical prostate cancer ? Overview of Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Dynamic Contrast-Enhanced MRI (DCE-MRI), MR spectroscopic Imaging (MRSI), Photoacoustic Imaging (PAI) -- 2. Automated quantitative cell and tissue imaging technologies -- 3. Diagnostic and early prostate cancer imaging; imaging of advanced prostate cancer -- 4. Emerging radiation techniques -- 5. Radiation therapy and partial prostate irradiation -- 6. Prostate cancer screening: radiology perspectives -- 7. Preclinical imaging of metastasis and dormancy: clinical implications -- 8. Utility of CT in the management of prostate cancer -- 9. Nanotechnology, cancer diagnosis and treatments -- 10. Imaging approaches to distinguish lethal from non-lethal disease -- 11. Photoacoustic imaging -- 12. Molecular and anatomical imaging in drug development -- 13. Molecular imaging modalities including CT, PET, SPECT, MRI, MRS, Hyperpolarized MRI, Ultrasound, X-ray computed tomography, Fusion Imaging (Molecular/Anatomic) -- 14. Functional imaging (PET vs. SPECT) -- 15. Optical bioluminescence molecular imaging -- 16. Therapeutic radiopharmaceutical translational research imaging -- 17. Accuracy of magnetic resonance imaging for local staging of prostate cancer: diagnostic meta-analysis -- 18. Adjuvant radiotherapy for pathologically advanced prostate cancer: randomized clinical trial -- 19. High-intensity focused ultrasound (HIFU) with histopathological analysis -- 20. Image-directed, tissue-preserving focal therapy of prostate cancer with a novel deformable magnetic resonance-ultrasound (MR-US) registration system -- 21. Focal therapy for localized unifocal and multifocal prostate cancer -- 22. Focal cryotherapy for clinically unilateral, low to intermediate risk prostate cancer -- 23. Impact of obesity on clinico-pathologic outcomes after robot-assisted laparoscopic prostatectomy -- 24. Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy. 330 $aThe second of two companion books which address the biology and clinical aspects of prostate cancer. This volume, Prostate Cancer: Molecular & Diagnostic Imaging and Treatment Stategies, discusses both classic and the most recent imaging approaches for detection, early diagnosis and treatment of prostate cancer. The companion title, Cell & Molecular Biology of Prostate Cancer, covers classic and modern cell and molecular biology as well as genetics, epigenetics, mitochondrial dysfunctions and apoptosis, cancer stem cells, angiogenesis, progression to metastasis, and treatment strategies including clinical trials related to prostate cancer. Taken together, these volumes form one comprehensive and invaluable contribution to the literature. . 410 0$aAdvances in Experimental Medicine and Biology,$x0065-2598 ;$v1126 606 $aCell cycle 606 $aMolecular biology 606 $aCancer research 606 $aUrology 606 $aRadiology 606 $aCell Cycle Analysis$3https://scigraph.springernature.com/ontologies/product-market-codes/L16030 606 $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X 606 $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001 606 $aUrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H62002 606 $aDiagnostic Radiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H29013 615 0$aCell cycle. 615 0$aMolecular biology. 615 0$aCancer research. 615 0$aUrology. 615 0$aRadiology. 615 14$aCell Cycle Analysis. 615 24$aMolecular Medicine. 615 24$aCancer Research. 615 24$aUrology. 615 24$aDiagnostic Radiology. 676 $a616.99463 702 $aSchatten$b Heide$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910298405203321 996 $aMolecular & Diagnostic Imaging in Prostate Cancer$92527083 997 $aUNINA